The store will not work correctly when cookies are disabled.
(2,5-dioxopyrrolidin-1-yl)naphthalene-2-sulfonate
ID: ALA4846927
PubChem CID: 22082177
Max Phase: Preclinical
Molecular Formula: C14H11NO5S
Molecular Weight: 305.31
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1CCC(=O)N1OS(=O)(=O)c1ccc2ccccc2c1
Standard InChI: InChI=1S/C14H11NO5S/c16-13-7-8-14(17)15(13)20-21(18,19)12-6-5-10-3-1-2-4-11(10)9-12/h1-6,9H,7-8H2
Standard InChI Key: SSWULYWUYZXRHV-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
38.1108 -14.9571 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.9003 -14.1688 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
37.3229 -14.7452 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.4487 -14.6517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2659 -14.6517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5203 -13.8750 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.8573 -13.3929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1986 -13.8750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8561 -12.5757 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.7455 -15.3134 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.2978 -13.6235 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.6819 -13.9197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.2843 -14.4741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.0652 -14.2257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.8510 -13.1217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6296 -12.8703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2362 -13.4233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0165 -13.1741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.1912 -12.3722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.5795 -11.8200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.8016 -12.0722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 4 1 0
7 9 2 0
5 10 2 0
6 11 1 0
11 2 1 0
2 12 1 0
12 13 2 0
13 14 1 0
14 17 2 0
16 15 2 0
15 12 1 0
16 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 305.31 | Molecular Weight (Monoisotopic): 305.0358 | AlogP: 1.61 | #Rotatable Bonds: 3 |
Polar Surface Area: 80.75 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 1.75 | CX LogD: 1.75 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.80 | Np Likeness Score: -0.71 |
References
1. Parsons WH, Rutland NT, Crainic JA, Cardozo JM, Chow AS, Andrews CL, Sheehan BK.. (2021) Development of succinimide-based inhibitors for the mitochondrial rhomboid protease PARL., 49 [PMID:34311087] [10.1016/j.bmcl.2021.128290] |